Wilson Sonsini Goodrich & Rosati advised Vida Ventures on IP matters related to the transaction.Third Arc Bio Inc., a biotech company, announced a $165 million oversubscribed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
